Analyst Ratings For NASDAQ:ABMD – ABIOMED (NASDAQ:ABMD)
Today, Jefferies Group raised its price target on NASDAQ:ABMD – ABIOMED (NASDAQ:ABMD) to per share.
Some recent analyst ratings include
- 4/4/2018-Goldman Sachs Group initiated coverage with a Buy ➝ Buy rating.
- 2/16/2018-SunTrust Banks Reiterated Rating of Buy.
- 2/4/2018-BTIG Research Reiterated Rating of Hold.
Recent Insider Trading Activity For NASDAQ:ABMD – ABIOMED (NASDAQ:ABMD)
NASDAQ:ABMD – ABIOMED (NASDAQ:ABMD) has insider ownership of 7.00% and institutional ownership of 87.79%.
- On 5/8/2018 Martin P Sutter, Director, sold 21,890 with an average share price of $343.50 per share and the total transaction amounting to $7,519,215.00.
- On 5/7/2018 Michael G Howley, VP, sold 17,500 with an average share price of $348.11 per share and the total transaction amounting to $6,091,925.00.
- On 5/7/2018 William J Bolt, SVP, sold 22,790 with an average share price of $348.03 per share and the total transaction amounting to $7,931,603.70.
- On 2/20/2018 Andrew J Greenfield, VP, sold 20,000 with an average share price of $270.36 per share and the total transaction amounting to $5,407,200.00.
- On 10/30/2017 Dorothy E Puhy, Director, sold 6,364 with an average share price of $179.08 per share and the total transaction amounting to $1,139,665.12.
- On 10/30/2017 Michael G Howley, VP, sold 10,000 with an average share price of $178.64 per share and the total transaction amounting to $1,786,400.00.
- On 10/2/2017 Andrew J Greenfield, VP, sold 11,282 with an average share price of $169.32 per share and the total transaction amounting to $1,910,268.24.
Recent Trading Activity for NASDAQ:ABMD – ABIOMED (NASDAQ:ABMD)
Shares of NASDAQ:ABMD – ABIOMED closed the previous trading session at 393.41 down -0.87 0.22% with shares trading hands.